Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient.
A 27-year-old man, who has been using risperidone for two months as the treatment for schizophrenia, with no previous history of diabetes was admitted to the hospital with the presentation of severe diabetes ketoacidosis and subsequent fatal progression.
Lu
Chieh-Hsiang
CH
Division of Endocrinology and Metabolism, Department of Internal Medicine, Chia-Yi Christian Hospital, Chia-Yi 600, Taiwan. chhslu@gmail.com
Yan
Yuan-Horng
YH
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000175:diagnosis; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000175:diagnosis; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D018967:Risperidone / Q000009:adverse effects*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*
D014150:Antipsychotic Agents; D018967:Risperidone